Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Isra Marei

Showing results (1-10 of 19) with videos related to

Pageof 2
Sort By:
Frontiers in Pharmacology|October 27, 2022
Biofunctionalization of cardiovascular stents to induce endothelialization: Implications for in- stent thrombosis in diabetesIsra Marei, Blerina Ahmetaj-Shala, Chris R Triggle
International Journal of Molecular Sciences|February 15, 2022
Recent Developments in Nanomaterials-Based Drug Delivery and Upgrading Treatment of Cardiovascular DiseasesNura A Mohamed, Isra Marei, Sergio Crovella, et al.
British Journal of Pharmacology|December 31, 2013
Metformin modulates hyperglycaemia-induced endothelial senescence and apoptosis through SIRT1Gnanapragasam Arunachalam, Samson Mathews Samuel, Isra Marei, et al.
Tissue Engineering. Part A|June 24, 2015
Assessment of Parylene C Thin Films for Heart Valve Tissue EngineeringIsra Marei, Adrian Chester, Ivan Carubelli, et al.
Canadian Journal of Physiology and Pharmacology|March 10, 2020
Why the endothelium? The endothelium as a target to reduce diabetes-associated vascular diseaseChris R Triggle, Hong Ding, Isra Marei, et al.
Canadian Journal of Physiology and Pharmacology|May 26, 2012
The endothelium: influencing vascular smooth muscle in many waysChris R Triggle, Samson Mathews Samuel, Shalini Ravishankar, et al.
Current Medicinal Chemistry|August 1, 2022
Repurposing Metformin for Vascular DiseaseChris R Triggle, Isra Marei, Kevin Ye, et al.
Frontiers in Cardiovascular Medicine|March 21, 2022
3D Tissue-Engineered Vascular Drug Screening Platforms: Promise and ConsiderationsIsra Marei, Tala Abu Samaan, Maryam Ali Al-Quradaghi, et al.
Metabolism: Clinical and Experimental|May 31, 2022
Metformin: Is it a drug for all reasons and diseases?Chris R Triggle, Ibrahim Mohammed, Khalifa Bshesh, et al.
Angiology|August 14, 2012
Association of adiponectin gene polymorphism (+T45G) with acute coronary syndrome and circulating adiponectin levelsNasser M Rizk, Ayman El-Menyar, Isra Marei, et al.
Pageof 2

Showing results (1-10 of 19) with videos related to

Sort By:
Pageof 2
Frontiers in Pharmacology|October 27, 2022
Biofunctionalization of cardiovascular stents to induce endothelialization: Implications for in- stent thrombosis in diabetesIsra Marei, Blerina Ahmetaj-Shala, Chris R Triggle
International Journal of Molecular Sciences|February 15, 2022
Recent Developments in Nanomaterials-Based Drug Delivery and Upgrading Treatment of Cardiovascular DiseasesNura A Mohamed, Isra Marei, Sergio Crovella, et al.
British Journal of Pharmacology|December 31, 2013
Metformin modulates hyperglycaemia-induced endothelial senescence and apoptosis through SIRT1Gnanapragasam Arunachalam, Samson Mathews Samuel, Isra Marei, et al.
Tissue Engineering. Part A|June 24, 2015
Assessment of Parylene C Thin Films for Heart Valve Tissue EngineeringIsra Marei, Adrian Chester, Ivan Carubelli, et al.
Canadian Journal of Physiology and Pharmacology|March 10, 2020
Why the endothelium? The endothelium as a target to reduce diabetes-associated vascular diseaseChris R Triggle, Hong Ding, Isra Marei, et al.
Canadian Journal of Physiology and Pharmacology|May 26, 2012
The endothelium: influencing vascular smooth muscle in many waysChris R Triggle, Samson Mathews Samuel, Shalini Ravishankar, et al.
Current Medicinal Chemistry|August 1, 2022
Repurposing Metformin for Vascular DiseaseChris R Triggle, Isra Marei, Kevin Ye, et al.
Frontiers in Cardiovascular Medicine|March 21, 2022
3D Tissue-Engineered Vascular Drug Screening Platforms: Promise and ConsiderationsIsra Marei, Tala Abu Samaan, Maryam Ali Al-Quradaghi, et al.
Metabolism: Clinical and Experimental|May 31, 2022
Metformin: Is it a drug for all reasons and diseases?Chris R Triggle, Ibrahim Mohammed, Khalifa Bshesh, et al.
Angiology|August 14, 2012
Association of adiponectin gene polymorphism (+T45G) with acute coronary syndrome and circulating adiponectin levelsNasser M Rizk, Ayman El-Menyar, Isra Marei, et al.
Pageof 2